CD209 and carcinoma: Consistently, immunostaining using CD80, a marker specific for M1, and CD209, a marker specific for M2a, showed that the various macrophages retained the expression of their respective markers after 36 h, even within the 3D collagen matrix in the presence of carcinoma aggregates and HUVECs (Figure 2).